Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma.
Tucker MD, Brown LC, Chen YW, Kao C, Hirshman N, Kinsey EN, Ancell KK, Beckermann KE, Davis NB, McAlister R, Schaffer K, Armstrong AJ, Harrison MR, George DJ, Rathmell WK, Rini BI, Zhang T.
Tucker MD, et al. Among authors: armstrong aj.
Biomark Res. 2021 Nov 3;9(1):80. doi: 10.1186/s40364-021-00334-4.
Biomark Res. 2021.
PMID: 34732251
Free PMC article.